Verywell Health on MSN
What you need to know about triple-negative breast cancer with chemo resistance
Medically reviewed by Marla Anderson, MD Key Takeaways Triple-negative breast cancer is aggressive and often resists ...
A groundbreaking study reveals that sacituzumab govitecan and pembrolizumab significantly enhance survival in untreated metastatic triple-negative breast cancer patients.
Datroway significantly improves overall and progression-free survival in metastatic triple-negative breast cancer patients ineligible for immunotherapy. TROPION-Breast02 trial results highlight ...
In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus pembrolizumab resulted in durable responses with improved progression free ...
March 28, 2007 — A new study clearly reveals the survival disadvantage for the so-called "triple-negative" subtype of breast cancer compared with other types of breast cancer. These tumors test ...
KILLEEN, Texas — When Shewanna Strickland went in for a routine mammogram in April 2024, just after turning 50, she never imagined the journey that lay ahead. What started as a concerning spot on her ...
Beta-blockers may fight the progression of triple-negative breast cancer, researchers have found Getty Beta blockers — a commonly prescribed blood pressure medication — may be useful in stopping the ...
CytoDyn (CYDY) announced that breast cancer specialist and medical oncologist, Milana V. Dolezal, MD, MSci, is presenting a poster entitled “Prolonged survival following PD-L1/PD-1 immune checkpoint ...
KILLEEN, Texas — When Shewanna Strickland went in for a routine mammogram in April 2024, just after turning 50, she never imagined the journey that lay ahead. What started as a concerning spot on her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results